CN Patent

CN115887372A — 丙酸氟替卡松混悬液及其制备方法

Assigned to Suzhou Aokangweishi Biotechnology Co ltd · Expires 2023-04-04 · 3y expired

What this patent protects

本发明涉及眼科药物技术领域，具体而言，涉及一种丙酸氟替卡松混悬液及其制备方法。该丙酸氟替卡松混悬液包含i)以治疗有效量存在且粒径≤1.5μm的丙酸氟替卡松，ii)0.1％w/w～1.0％w/w甲基纤维素，和iii)所述丙酸氟替卡松难溶的水性溶剂。

USPTO Abstract

本发明涉及眼科药物技术领域，具体而言，涉及一种丙酸氟替卡松混悬液及其制备方法。该丙酸氟替卡松混悬液包含i)以治疗有效量存在且粒径≤1.5μm的丙酸氟替卡松，ii)0.1％w/w～1.0％w/w甲基纤维素，和iii)所述丙酸氟替卡松难溶的水性溶剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN115887372A
Jurisdiction
CN
Classification
—
Expires
2023-04-04
Drug substance claim
No
Drug product claim
No
Assignee
Suzhou Aokangweishi Biotechnology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.